N. Daftarian, S. Zandi, G. Piryaie, M. Zarif, E. Pirmardan, M. Yamaguchi, Q. Nejad, H. Hasanpour, S. Samiei, I. Pfister, Z. Soheili, S. Nakao, A. Barakat, J. Garweg, H. Ahmadieh, A. Hafezi-Moghadam
Peripheral blood CD163(+) monocytes and soluble CD163 in dry and neovascular age-related macular degeneration
30.3.2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020;00: 111. https://doi.org/10.1096/fj.20190 1902RR
C. Kaya, I. Pfister, C. Gerhardt, J. Garweg
Outcome of treatment for neovascular age-related macular degeneration by practice-based ophthalmologists compared with a macula center
27.3.2020, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, doi:s00417-020-04667-y
S. Zandi , F. Freiberg, V. Vaclavik, I. Pfister, P. Traine, C. Kaya, S. Michels, J. Garweg
Morphological Reconstitution and Persistent Changes After Intravitreal Ocriplasmin for Vitreomacular Traction and Macular Hole
22.1.2020, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, DOI: 10.1089/jop.2019.0051
J. Garweg , D. Ouassi, I. Pfister
Hybrid 23/27 Gauge Vitrectomy – Combining the Charm of 27G with the Efficacy of 23G
2020, Clinical ophthalmology (Auckland, N.Z.), 2020:14 299-305
P. Traine, I. Pfister, S. Zandi, J. Spindler, J. Garweg
Long-term Outcome of Intravitreal Aflibercept Treatment for Neovascular Age-Related Macular Degeneration Using a „Treat-and-Extend“ Regimen
1.5.2019, Ophthalmology Retina, Volume 3, Number 5, May 2019, https://doi.org/10.1016/j.oret.2019.01.018
S. Zandi, I. Pfister, P. Traine, C. Tappeiner, A. Despont, R. Rieben, M. Skowronska, J. Garweg
Biomarkers for PVR in rhegmatogenous retinal detachment
3.4.2019, Public Library of Science, 14(4):e0214674. doi: 10.1371/journal.pone.0214674. eCollection 2019
J. Garweg
Pharmacological treatment strategies and surgical options for uveitis
22.2.2019, Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, doi: 10.1007/s00347-019-0870-x. [Epub ahead of print] Review. German. PubMed PMID: 30796601
J. Garweg, J. Messerli
Diagnostic Strategy and Therapeutic Dilemma in Acute Posterior and Panuveitis
14.2.2019, Klinische Monatsblätter für Augenheilkunde, doi: 10.1055/a-0828-7395. [Epub ahead of print]
C. Kaya , S. Zandi, I. Pfister, C. Gerhardt, J. Garweg
Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration
2019, Clinical ophthalmology (Auckland, N.Z.), 2019:13 2403-2409
P. Traine, C. Scheib, J. Garweg
Choroidal Neovascularization Resulting from Angioid Streaks in Pseudoxanthoma Elasticum
2019, Ophthalmology Retina, 3(1):31. doi: 10.1016/j.oret.2018.10.007. PubMed PMID: 30929814
J. Garweg, S. Zandi, I. Pfister, R. Rieben, M. Skowronska, C. Tappeiner
Cytokine profiles of phakic and pseudophakic eyes with primary retinal detachment
18.12.2018, Acta ophthalmologica, . doi: 10.1111/aos.13998. [Epub ahead of print] PubMed
J. Spindler, S. Zandi, I. Pfister, C. Gerhardt, J. Garweg
Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration
29.8.2018, Public Library of Science, 13(8):e0203337. doi: 10.1371/journal.pone.0203337
H. Ahmadieh, R. Nourinia, A. Hafezi-Moghadam, H. Sabbaghi, S. Nakao, S. Zandi, M. Yaseri, Z. Tofighi, S. Akbarian
Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trial
27.8.2018, The British journal of ophthalmology, pii: bjophthalmol-2018-312244. doi: 10.1136/bjophthalmol-2018-312244. [Epub ahead of print]
J. Garweg, J. Zirpel, C. Gerhardt, I. Pfister
Past and prognosis of anti-VEGF therapy for wet age-related macular degeneration-the future has begun
1.8.2018, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 256(8):1553-1555. doi: 10.1007/s00417-018-4005-x. Epub 2018 May 9. PubMed PMID: 29744574
P. Maloca, P. Hasler, D. Barthelmes, P. Arnold, M. Mooser, H. Scholl, H. Gerding, J. Garweg, T. Heeren, K. Balaskas, J. de Carvalho, C. Egan, A. Tufail, S. Zweifel
Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring
1.7.2018, Translational vision science and technology, 24 7(4):8. doi: 10.1167/tvst.7.4.8
J. Garweg
Macular Edema in Childhood Uveitis
1.4.2018, Klinische Monatsblätter für Augenheilkunde, 235:373-376
J. Garweg, J. Zirpel, C. Gerhardt, I. Pfister
The fate of eyes with wet AMD beyond four years of anti-VEGF therapy
1.4.2018, Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie, 256(4):823-831. doi: 10.1007/s00417-018-3907-y
J. Garweg, M. Deiss, I. Pfister, C. Gerhardt
IMPACT OF INNER LIMITING MEMBRANE PEELING ON VISUAL RECOVERY AFTER VITRECTOMY FOR PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT INVOLVING THE FOVEA
1.2.2018, Retina (Philadelphia, Pa.), doi: 10.1097/IAE.0000000000002046
S. Zandi, B. Bodaghi, J. Garweg
Review for Disease of the Year: Treatment of Viral Anterior Uveitis: A Perspective
2018, Ocular immunology and inflammation, 26(7):1135-1142. doi: 10.1080/09273948.2018.1498109. Epub 2018 Aug 10
J. Garweg, S. Niderprim, H. Russ, I. Pfister
Comparison of Strategies of Treatment with Ranibizumab in Newly-Diagnosed Cases of Neovascular Age-Related Macular Degeneration
1.12.2017, Journal of ocular pharmacology and therapeutics: the official journal of the Association for Ocular Pharmacology and Therapeutics, 33(10):773-778. doi: 10.1089/jop.2017.0006
